These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19899977)

  • 21. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation methods using tear volume in a conjunctivitis mice model.
    Kai H; Haraoka N; Sugimoto Y
    J Pharmacol Toxicol Methods; 2024; 128():107520. PubMed ID: 38830514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Roles of cytokines in the development of severe allergic conjunctival diseases: analyses using animal models].
    Fukushima A
    Nippon Ganka Gakkai Zasshi; 2004 Nov; 108(11):682-9. PubMed ID: 15584353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
    Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
    J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis.
    Schlereth S; Lee HS; Khandelwal P; Saban DR
    Am J Pathol; 2012 Jun; 180(6):2351-60. PubMed ID: 22507838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
    Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial tears inhibit the development of experimental immune-mediated blepharoconjunctivitis.
    Fukushima A; Zinchuk O; Ueno H
    Jpn J Ophthalmol; 2004; 48(6):530-4. PubMed ID: 15592776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Allergic Conjunctivitis Induced by House Dust Mite Extract From Dermatophagoides pteronyssinus.
    Lee YJ; Han SJ; Lee H; Kim JS; Seo KY
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1773-81. PubMed ID: 27074380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
    Schopf L; Luccioli S; Bundoc V; Justice P; Chan CC; Wetzel BJ; Norris HH; Urban JF; Keane-Myers A
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis.
    Fukuda K; Kuo CH; Morohoshi K; Liu FT; Ono SJ
    Br J Ophthalmol; 2012 Aug; 96(8):1132-6. PubMed ID: 22694967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.
    Ueta M; Matsuoka T; Narumiya S; Kinoshita S
    J Allergy Clin Immunol; 2009 Feb; 123(2):466-71. PubMed ID: 18996575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
    Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G; Ajayi Y; Stern ME; Calder VL
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of Epithelial Cell-Derived Type 2-Initiating Cytokines in Experimental Allergic Conjunctivitis.
    Asada Y; Nakae S; Ishida W; Hori K; Sugita J; Sudo K; Fukuda K; Fukushima A; Suto H; Murakami A; Saito H; Ebihara N; Matsuda A
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5194-202. PubMed ID: 26244295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis.
    Gimenes AD; Andrade TR; Mello CB; Ramos L; Gil CD; Oliani SM
    Exp Eye Res; 2015 May; 134():24-32. PubMed ID: 25795053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antigen-specific T cells in experimental immune-mediated blepharoconjunctivitis in DO11.10 T cell receptor transgenic mice.
    Ozaki A; Ishida W; Fukata K; Fukushima A; Ueno H
    Microbiol Immunol; 2004; 48(1):39-48. PubMed ID: 14734856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.